Calorie restriction, physical activity and the drug dapagliflozin caused 44% of participants in a small trial to enter diabetes remission Dapagliflozin is a sodium glucose co-transporter 2 (SGLT2) ...

These medications began as diabetes treatments to lower blood glucose levels and have now been approved to help people without diabetes lose weight. But because they have been used for longer as ...